Uterine fibroids

Indication for Triptorelin

Population group: Suitable for women, only adults (18 years old or older)

Treatment of uterine fibroids prior to surgery or when surgery is not appropriate.

For this indication, competent medicine agencies globally authorize below treatments:

4.2 mg once every 28 days

Route of admnistration


Defined daily dose

4.2 - 4.2 mg

Dosage regimen

From 4.2 To 4.2 mg once every 28 day(s)

Detailed description

4.2 mg every 28 days. For the treatment of uterine fibroids the treatment must be initiated in the first five days of the cycle. The maximum duration of treatment should be 6 months. For patients with uterine fibroids triptorelin should be administered for a minimum of 3 months.

Active ingredient

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Read more about Triptorelin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner